Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Fenofibrate and Atorvastatin in Healthy Volunteers
NCT02066207Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Mar 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in dyslipidemia comparing Fenofibrate, Atorvastatin and Fenofibrate + Atorvastatin (3 arms). Primary endpoints: Area Under the Concentration-Time Curve to the Last Measurable Concentration and Maximum Plasma Concentration at Steady State. Started Mar 2014; status: completed.
02
Drugs
fenofibrateatorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02066207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066207.